Skip to main content

Table 1 The base case analysis for all the strategies with ‘days until the first event (myocardial infarction, stroke or death)’ as the health outcome and cost until death

From: Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data

Strategies Number of pairs included in the strategy Time free of event in days for participants mean (SE) Time free of events in controls mean (SE) Difference of days free of event per pair mean (SE) Difference in time free of event in days study population (SE) Difference of costs per pair in €* mean (SE) Difference in cost in €* study population (SE) ICER (€/year)
KardioPro for all risk groups 13,112 629.56 629.39 3.17 41,514 674.35 8,842,036 77,742
(1.62) (1.65) (0.84) (11,070) (133.82) (1,754,657)
KardioPro for CHD group 1,411 599.35 592.81 6.54 9,226 473.92 668,696 26,456
(4.95) (5.17) (4.42) (6,238) (607.67) (857,428)
KardioPro for high-risk group 964 606.33 595.77 10.56 10,182 604.79 583,014 20,901
(5.80) (6.02) (4.29) (4,136) (555.02) (535,035)
KardioPro for medium-risk group 1,729 604.94 599.13 5.81 10,041 832.47 1,439,334 52,323
(4.29) (4.40) (2.62) (4,537) (425.73) (736,090)
KardioPro for low-risk group 9,008 641.50 640.16 1.34 12,066 682.84 6,150,992 186,074
(1.96) (1.98) (0.74) (6,694) (138.69) (1,249,335)
KardioPro for CHD and high- and medium-risk group 4,104 603.34 596.17 7.18 29,558 655.71 2,690,846 33,251
(2.83) (2.93) (2.13) (8,761) (304.32) (1,261,563)
KardioPro for CHD and high-risk group 2,375 602.18 594.01 8.17 19,344 527.04 1,254,061 23,678
(3.77) (3.93) (3.16) (7,501) (425.34) (1,000,480)
KardioPro for high- and medium-risk group 2,693 605.44 597.93 7.51 20,241 750.96 2,016,933 36,395
(3.45) (3.55) (2.28) (6,019) (337.36) (910,159)
  1. *Only the difference in costs between intervention and control group are displayed, as the absolute values are confidential.
  2. CHD: coronary heart diseases.
  3. ICER: incremental cost-effectiveness ratio.
  4. SE: standard error.
  5. Costs were inflated to the year 2010. Both costs and effects were discounted at 5%.